• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：新型喹唑啉酮标记的噻吩、噻吩并嘧啶和噻吩并吡啶支架的设计、合成及作为具有潜在p38α丝裂原活化蛋白激酶抑制作用的抗增殖剂的研究。

Correction: Design, synthesis, and studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects.

作者信息

Alsfouk Aisha A, Othman Ismail M M, Anwar Manal M, Saleh Asmaa, Nossier Eman S

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University P. O. Box 84428 Riyadh 11671 Saudi Arabia.

Department of Chemistry, Faculty of Science, Al-Azhar University Assiut 71524 Egypt.

出版信息

RSC Adv. 2025 Jan 27;15(4):2758. doi: 10.1039/d5ra90011e. eCollection 2025 Jan 23.

DOI:10.1039/d5ra90011e
PMID:39871970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11770409/
Abstract

[This corrects the article DOI: 10.1039/D4RA06744D.].

摘要

[本文更正了文章的数字对象标识符：10.1039/D4RA06744D。]

相似文献

1
Correction: Design, synthesis, and studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects.更正：新型喹唑啉酮标记的噻吩、噻吩并嘧啶和噻吩并吡啶支架的设计、合成及作为具有潜在p38α丝裂原活化蛋白激酶抑制作用的抗增殖剂的研究。
RSC Adv. 2025 Jan 27;15(4):2758. doi: 10.1039/d5ra90011e. eCollection 2025 Jan 23.
2
Design, synthesis, and studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects.新型喹唑啉酮标记的噻吩、噻吩并嘧啶和噻吩并吡啶支架作为具有潜在p38α丝裂原活化蛋白激酶抑制作用的抗增殖剂的设计、合成及研究
RSC Adv. 2025 Jan 16;15(2):1407-1424. doi: 10.1039/d4ra06744d. eCollection 2025 Jan 9.
3
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells.强效V型丝裂原活化蛋白激酶抑制剂的开发：针对乳腺癌细胞中p38α丝裂原活化蛋白激酶的苯并噻唑衍生物的设计、合成及生物学评价
Arch Pharm (Weinheim). 2025 Apr;358(4):e2500011. doi: 10.1002/ardp.202500011.
4
Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies.鉴定新型 5-(2,6-二氯苯基)-3-氧代-2,3-二氢-5H-噻唑并[3,2-a]嘧啶-7-羧酸衍生物作为 p38α MAPK 抑制剂：设计、合成、抗肿瘤评估、分子对接和计算机模拟研究。
Bioorg Chem. 2024 Apr;145:107226. doi: 10.1016/j.bioorg.2024.107226. Epub 2024 Feb 18.
5
Design, Synthesis, and Biological Evaluation of Tetra-Substituted Thiophenes as Inhibitors of p38α MAPK.四取代噻吩类 p38α MAPK 抑制剂的设计、合成与生物评价。
ChemistryOpen. 2015 Feb;4(1):56-64. doi: 10.1002/open.201402076. Epub 2014 Nov 11.
6
New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitors.新型噻吩、噻吩并吡啶和噻唑啉基衍生物：作为抗增殖剂和多靶点激酶抑制剂的设计、合成及生物学评价
Bioorg Chem. 2022 Oct;127:105964. doi: 10.1016/j.bioorg.2022.105964. Epub 2022 Jun 14.
7
Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study.对 4-(咪唑-5-基)吡啶衍生物进行结构优化，得到具有广谱抗癌活性和选择性 B-RAF/p38α 激酶抑制活性的化合物：合成、体外评价及计算机模拟研究。
Eur J Pharm Sci. 2022 Apr 1;171:106115. doi: 10.1016/j.ejps.2022.106115. Epub 2022 Jan 4.
8
Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site.计算机辅助药物重新定位策略在变构位点靶向P38α丝裂原活化蛋白激酶（MAPK）中的整合
Pharmaceutics. 2022 Jul 13;14(7):1461. doi: 10.3390/pharmaceutics14071461.
9
Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitors.喹喔啉衍生物作为有效的p38α丝裂原活化蛋白激酶抑制剂的设计、合成、生物学评价及计算机模拟研究
Arch Pharm (Weinheim). 2024 Jan;357(1):e2300301. doi: 10.1002/ardp.202300301. Epub 2023 Oct 17.
10
In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers.新型稠合噻吩衍生物作为VEGFR-2/AKT双重抑制剂和凋亡诱导剂的体外抗癌活性筛选
Pharmaceuticals (Basel). 2022 Jun 2;15(6):700. doi: 10.3390/ph15060700.

引用本文的文献

1
Design, antiproliferative potency, and in silico studies of novel 5-methylfuran-3-yl)thio)-3-phenylquinazolin-4(3H)-one based derivatives as potential EGFR inhibitors.新型5-甲基呋喃-3-基）硫代）-3-苯基喹唑啉-4（3H）-酮类衍生物作为潜在表皮生长因子受体（EGFR）抑制剂的设计、抗增殖活性及计算机模拟研究
Sci Rep. 2025 Jul 31;15(1):27992. doi: 10.1038/s41598-025-12140-1.